Michael A. Panzara
CIK 1679039 · Chief Medical Officer · last filed 2026-04-29
Michael A. Panzara is a Chief Medical Officer who has filed 23 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for IMUX, was dated Apr 29, 2026. Across all open-market trades the lifetime net is −$1.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $738.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$738.5K
4
23
-$1.68M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMUX | Chief Medical Officer | — | $13.86 | — | $0 | 1 | 2026-04-29 |
| LONA | Director | — | $8.35 | — | $0 | 1 | 2026-04-13 |
| LeonaBio, Inc. (ATHA) Delisted | Director | — | $6.92 | — | $0 | 5 | 2025-06-03 |
| WVE | See Remarks | 125,817 | $5.87 | $738.5K | -$1.68M | 16 | 2022-07-27 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-29 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2026-04-13 | LONA | Grant (A) | — | $0 | EDGAR |
| 2025-06-03 | LeonaBio, Inc. (ATHA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-24 | LeonaBio, Inc. (ATHA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-22 | LeonaBio, Inc. (ATHA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-07-27 | WVE | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | LeonaBio, Inc. (ATHA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-06 | WVE | Mixed | +33,286 | -$28.7K | EDGAR |
| 2022-03-21 | LeonaBio, Inc. (ATHA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-18 | WVE | Sell (S) | −10,603 | -$24.5K | EDGAR |